电邮这篇文章 在隔离观察期间的新型冠状病毒感染学生的临床病程特点
- 作者: Kuznetsova O.Y.1, Lubimova A.V.1, Ovakimyan K.V.1, Zamyatina O.S.1, Donetskov N.V.1
-
隶属关系:
- North-Western State Medical University named after I.I. Mechnikov
- 期: 卷 24, 编号 4 (2020)
- 页面: 5-12
- 栏目: Original study article
- URL: https://medbiosci.ru/RFD/article/view/57155
- DOI: https://doi.org/10.17816/RFD57155
- ID: 57155
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
新型冠状病毒感染（COVID-19）疫情已被列为具有国际重要性的紧急情况，不仅引起了卫生专业人员的关注，也引起了全世界人民的关注。尽管没有伴随疾病的年轻人因COVID-19造成严重健康后果的风险相对较低，在这一年龄组中，感染的传播可能导致与他们有密切接触的老年人群的发病率增加。这些人有较高的死于COVID-19的风险。
该研究的目的是在隔离观察期间评估一种新型冠状病毒感染在North-western State Medical University named after I.I. Mechnikov的学生中的临床过程特征。
材料与方法。这项研究是在North-western State Medical University named after I.I. Mechnikov医学观察站进行的。那里的学生接触过新型冠状病毒感染者，有轻度症状，也有急性呼吸道疾病的临床表现。2020年4月21日至8月31日转入隔离的所有学生均有流行病学和临床病历资料。作为前瞻性研究的一部分，所有参与者在隔离3个月后，都被要求通过电话完成一份健康量表（EQ-5D）。
结果。这项研究包括113名参与者：45.1%的男性（n = 51）和54.9%的女性（n = 62）。调查对象平均年龄为22.4±2.5岁。在进行多变量分析时，发现性别、年龄、所属人种语言群体和慢性疾病不是与COVID-19发生相关的可靠因素。前瞻性研究结果显示，COVID-19康复患者与普通患者在回答疾病急性期3个月后持续不适或疼痛的问题时，差异有统计学意义（p < 0.05）。
作者简介
Olga Kuznetsova
North-Western State Medical University named after I.I. Mechnikov
Email: olga.kuznetsova@szgmu.ru
ORCID iD: 0000-0002-2440-6959
SPIN 代码: 7200-8861
Scopus 作者 ID: 24448739500
Researcher ID: O-4056-2014
DSc, Professor, Head of the Department of Family Medicine
俄罗斯联邦, Saint-PetersburgAnna Lubimova
North-Western State Medical University named after I.I. Mechnikov
Email: lubimova@gmail.com
SPIN 代码: 8967-4868
Researcher ID: O-9927-2014
PhD, Professor of Epidemiology Department
俄罗斯联邦, Saint-PetersburgKarina Ovakimyan
North-Western State Medical University named after I.I. Mechnikov
编辑信件的主要联系方式.
Email: ursa-alba@yandex.ru
Assistant Professor of the Department of Family Medicine
俄罗斯联邦, Saint-PetersburgOlga Zamyatina
North-Western State Medical University named after I.I. Mechnikov
Email: olyazamiatina@yandex.ru
ORCID iD: 0000-0001-7011-7157
District physician, resident of the Department of Family Medicine
俄罗斯联邦, Saint-PetersburgNikita Donetskov
North-Western State Medical University named after I.I. Mechnikov
Email: nikdonetskov@gmail.com
ORCID iD: 0000-0003-4124-6747
SPIN 代码: 8961-2139
District physician, resident of Infectious diseases Department
俄罗斯联邦, Saint-Petersburg参考
- Wuhan Municipal Health Commission briefing of the pneumonia epidemic situation. 31 December 2019. WHO. (In Mandarin). Available from: http://wjw.wunan.gov.cn/front/web/showDetail/2019123108989.
- Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCov) infection is suspected, 28 January 2020. WHO. Available from: https://apps.who.int/iris/handle/10665/330893.
- Особенности эпидемиологии, клиники и стратегии ведения контактных лиц и пациентов с COVID-19 в КНР. – Минздрав России, 2020. Режим доступа: https://minzdrav.gov.ru/news/2020/03/03/13469-predstavlen-otchet-o-rabote-mezhdunarodnoy-missii-voz-po-probleme-covid-19. [Osobennosti ehpidemiologii, kliniki i strategii vedeniya kontaktnykh lits i patsientov s COVID-19 v KNR. Minzdrav Rossii; 2020. Available from: https://minzdrav.gov.ru/news/2020/03/03/13469-predstavlen-otchet-o-rabote-mezhdunarodnoy-missii-voz-po-probleme-covid-19. (In Russ.)]
- Naming the coronavirus disease (COVID-19) and the virus that causes it. WHO. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.
- Coronavirus disease (COVID-2019) situation reports. WHO. Available from: https:/www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
- Walke HT, Honein МА, Redfield RR. Preventing and Responding to COVID-19 on College Campuses. JAMA. 2020;324(17):1727–1728. Available from: https://jamanetwork.com/journals/jama/fullarticle/2771319. https://doi.org/10.1001/jama.2020.20027.
- Meng X, Deng Ya, Dai Zh, Meng Zh. COVID-19 and anosmia: A review based on up-to-date knowledge. Am J Otolaryngol. 2020;41(5):102581. https://doi.org/10.1016/j.amjoto.2020.102581.
- Lai C-C, Ko W-C, Lee P-I, et al. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020;56(2):106024. https://doi.org/10.1016/j.ijantimicag.2020.106024.
- Сайганов С.А., Мельцер А.В., Любимова А.В. и др. Опыт организации мер по предотвращению распространения новой коронавирусной инфекции среди обучающихся образовательной организации, проживающих в общежитиях // Профилактическая и клиническая медицина. – 2020. – Т. 76. – № 3. – С. 4–11. [Sayganov SA, Meltser AV, Liubimova AV, et al. Experience in measures development to prevent spread of new coronavirus disease among students of educational organization living in dormitories. Profclinmed. 2020;76(3):4–11. (In Russ.)]
- Клиническое исследование препаратов для лечения COVID-19 “Solidarity”. ВОЗ. Режим доступа: https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments. [Solidarity Trial reports interim results. WHO. Available from: https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments.]
- EVMS Critical care protocol COVID19. 2020. Available from: https://www.evms.edu/media/evms_public/departments/internal_medicine/EVMS_Critical_Care_COVID-19_Protocol.pdf.
- Опросник по здоровью. Версия на русском языке для России. Режим доступа: http://scem.spb.hse.ru/data/2020/03/10/1563014698/EQ-5D-3L.pdf. [Health Questionnaire. Available from: https://euroqol.org/eq-5d-instruments/eq-5d-3l-available-modes-of-administration/self-complete-for-use-in-qualtrics/]
- Greenhalgh T, Knight M, A’Court C, et al. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. https://doi.org/10.1136/bmj.m3026.
补充文件
